Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

A shorter course of prophylactic antibiotics, or even no course at all, appeared to be noninferior to longer courses in ...

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

In hospitalized patients with acute kidney injury and liver cirrhosis, baseline and peak levels of serum cystatin C can ...

States along the Gulf Coast have raised alarms about a rise in infections from flesh-eating bacteria. In Louisiana, doctors ...

Terry's nails, characterized by a white, frosted appearance with a narrow pink band, can indicate underlying health issues like liver cirrhosis, heart ...

Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue ...

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is ...

Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.